National Cancer Institute
Cancer Imaging Program

Imaging Guidelines for Clinical Trials

Dynamic contrast MRI (DCE-MRI) 1 - guidelines resulted from the NCI CIP MR Workshop on Translational Research in Cancer - Tumor Response, Bethesda, MD, November 22-23, 2004.

Magnetic resonance spectroscopy (MRS) 2 - guidelines resulted from the NCI CIP MR Workshop on Translational Research in Cancer - Tumor Response, Bethesda, MD, November 22-23, 2004.

Fluorodeoxyglucose PET (FDG PET) 3 - guidelines resulted from the NCI CIP workshop convened on January 10-11, 2005, in Washington, DC.



Table of Links

1http://dev1.cancer.gov/images/Documents/14a39040-dad1-46f8-bf88-bae2e7401ebe/DC
E_RecommendationfromNov2004NCIWorkshop(2).pdf
2http://dev1.cancer.gov/images/Documents/14a39040-dad1-46f8-bf88-bae2e7401ebe/MR
S_RecommendationfromNov2004NCIWorkshop.pdf
3http://dev1.cancer.gov/reportsandpublications/publications/Clinical-Trials-Guid
elines